Today, a Director at Cormedix Inc (NYSE MKT: CRMD), Matthew Duffy, sold shares of CRMD for $125.9k.
In addition to Matthew Duffy, 12 other CRMD executives reported Sell trades in the last month.
The company has a one year high of $6.27 and a one year low of $1.15. Currently, Cormedix Inc has an average volume of 233.3k.
Looking at blogger coverage of CRMD, there is a 100% Bearish tendency on the stock, in relation to an 80% average bullish tendency within the Healthcare sector.
In the last 30 days, insiders have sold $630.8k worth of CRMD shares and purchased $170.9k worth of CRMD shares. Over the last 3 months, the insider sentiment on Cormedix Inc has been negative based on 18 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.
CorMedix, Inc. operates as pharmaceutical and medical device company that seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Bridgewater, NJ.